Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Phase 1
Withdrawn
- Conditions
- Platinum-resistant ovarian cancer (PROC)Other advanced CDH6-positive cancersAdvanced renal cell carcinoma (RCC)
- Interventions
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-23
- Lead Sponsor
- Oncusp Therapeutics Inc.
- Target Recruit Count
- 20
- Registration Number
- 2024-519862-33-00
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen Oe, Denmark
🇪🇸Hospital Universitari Vall D Hebron, Barcelona, Spain
News
No news found